[Secondary hyperlipidemia due to endocrine disorders].
Yoshino
G
G
Second Department of Internal Medicine, Kobe University School of Medicine.
Maeda
E
E
D000310:Adrenal Gland Neoplasms / Q000150:complications; D000728:Androgens / Q000502:physiology; D003480:Cushing Syndrome / Q000150:complications; D004700:Endocrine System Diseases / Q000150:complications*; D004967:Estrogens / Q000502:physiology; D005934:Glucagon / Q000502:physiology; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology* / Q000378:metabolism; D007018:Hypopituitarism / Q000150:complications; D007328:Insulin / Q000502:physiology; D008049:Lipase / Q000378:metabolism; D050356:Lipid Metabolism; D010673:Pheochromocytoma / Q000150:complications; D013959:Thyroid Diseases / Q000150:complications
D000728:Androgens; D004967:Estrogens; D007328:Insulin; D005934:Glucagon; D008049:Lipase